| Atoosa Kashani, DPM | |
|
7540-i Little River Turnpike, Annandale, VA 22003-5152 | |
| (703) 750-1124 | |
| Not Available |
| Full Name | Atoosa Kashani |
|---|---|
| Gender | Female |
| Speciality | Podiatry |
| Experience | 20 Years |
| Location | 7540-i Little River Turnpike, Annandale, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437271889 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | 0103300978 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Inova Fairfax Hospital | Falls church, VA | Hospital |
| Provider Name | Podiatry Center-annandale Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1699876615 PECOS PAC ID: 5092882910 Enrollment ID: O20080918000427 |
News Archive
The cost of searching for the fountain of youth has become increasingly expensive and now exceeds the cost for medications used to treat chronic disease, according to new research released today at the American Public Health Association's 140th Annual Meeting in San Francisco, Calif.
Onyx Pharmaceuticals, Inc. today announced that the company has begun enrollment in the ASPIRE trial, a Phase 3 international clinical trial evaluating carfilzomib in combination with lenalidomide (Revlimid®) and low dose dexamethasone in patients with relapsed multiple myeloma. The company has an agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) and received Scientific Advice from the European Medicines Agency (EMA) on the design and planned analysis of the ASPIRE trial.
Celgene Corporation and Agios Pharmaceuticals Inc., a privately-held biotechnology company, today announced the formation of a global strategic collaboration focused on targeting cancer metabolism. The goal of the collaboration is to discover, develop, and deliver novel disease-altering therapies in oncology based on the transformational science of Agios' innovative cancer metabolism research platform. This platform is based on the concept that targeting key metabolic enzymes unique to rapidly proliferating cancer cells can "starve" the cancer.
The revolutionary bioengineered healing glove created by researchers at the University of Texas at Arlington Research Institute and the University of Washington has completed another key step on the road toward commercialization.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Atoosa Kashani, DPM 14803 Hartlaub Ct, Centreville, VA 20120-2962 Ph: (703) 401-6323 | Atoosa Kashani, DPM 7540-i Little River Turnpike, Annandale, VA 22003-5152 Ph: (703) 750-1124 |
News Archive
The cost of searching for the fountain of youth has become increasingly expensive and now exceeds the cost for medications used to treat chronic disease, according to new research released today at the American Public Health Association's 140th Annual Meeting in San Francisco, Calif.
Onyx Pharmaceuticals, Inc. today announced that the company has begun enrollment in the ASPIRE trial, a Phase 3 international clinical trial evaluating carfilzomib in combination with lenalidomide (Revlimid®) and low dose dexamethasone in patients with relapsed multiple myeloma. The company has an agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) and received Scientific Advice from the European Medicines Agency (EMA) on the design and planned analysis of the ASPIRE trial.
Celgene Corporation and Agios Pharmaceuticals Inc., a privately-held biotechnology company, today announced the formation of a global strategic collaboration focused on targeting cancer metabolism. The goal of the collaboration is to discover, develop, and deliver novel disease-altering therapies in oncology based on the transformational science of Agios' innovative cancer metabolism research platform. This platform is based on the concept that targeting key metabolic enzymes unique to rapidly proliferating cancer cells can "starve" the cancer.
The revolutionary bioengineered healing glove created by researchers at the University of Texas at Arlington Research Institute and the University of Washington has completed another key step on the road toward commercialization.
› Verified 8 days ago
Myles J Schneider, D.P.M Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 7540 Little River Tpke, Suite I, Annandale, VA 22003 Phone: 703-750-1124 Fax: 703-750-2043 | |
Alexandria Podiatry Associates Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 7023 Little River Tpke Ste 207, Annandale, VA 22003 Phone: 703-379-0700 Fax: 703-941-6963 | |
Robert A Breiner Pc Podiatrist Medicare: Medicare Enrolled Practice Location: 5105 Backlick Rd., Suite S, Annandale, VA 22003 Phone: 703-941-7770 | |
Dr. Rebecca Anne Metz, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 5105 Backlick Rd, Suite S, Annandale, VA 22003 Phone: 703-941-7770 Fax: 703-941-7771 | |
Loudoun Medical Group, Pc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 7023 Little River Turnpike, Suite 207, Annandale, VA 22003 Phone: 703-379-0700 Fax: 703-941-6963 | |
The Foot Doctor, Pllc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 3301 Woodburn Rd Ste 208, Annandale, VA 22003 Phone: 703-942-9845 |